ALISSA STEELE: Open Payments
NPI 1750833513 · SAULT SAINTE MARIE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,758 in 164 payments from 20 companies in 2025. Trend: 2023 $2,779 · 2024 $2,804 · 2025 $3,758
Food & beverage: $3,608Education: $150
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 36 | $1,147 |
| ABBVIE INC. | 28 | $476 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 17 | $310 |
| GENZYME CORPORATION | 5 | $286 |
| UCB, Inc. | 12 | $273 |
| Lilly USA, LLC | 19 | $209 |
| Regeneron Healthcare Solutions, Inc. | 5 | $171 |
| Organon LLC | 3 | $162 |
| Novartis Pharmaceuticals Corporation | 5 | $132 |
| Incyte Corporation | 4 | $117 |
Products named: TREMFYA, DUPIXENT, RINVOQ, Bimzelx, TALTZ, SKYRIZI, VTAMA, ILUMYA.
Industry payments across MI — which companies pay providers there.
